During the past decade, Kirkeparken Spesialistpraksis conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kirkeparken Spesialistpraksis" are "Endometriosis" (1 trials), "Hot Flashes" (1 trials), "Leiomyoma" (1 trials), "Uterine Fibroids" (1 trials) and "Vasomotor Symptoms Associated With Menopause" (1 trials). Many other conditions were trialed in "Kirkeparken Spesialistpraksis" in a lesser frequency.

Most popular intervention types in "Kirkeparken Spesialistpraksis" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Vilaprisan (BAY1002670)" (2 trials), "BAY1817080" (1 trials), "Elagolix" (1 trials) and "Elinzanetant (BAY3427080)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kirkeparken Spesialistpraksis" are 4 trials for "Female" genders.

Currently, there are NaN active trials in "Kirkeparken Spesialistpraksis". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kirkeparken Spesialistpraksis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kirkeparken Spesialistpraksis, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".